Dementia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Description
Dementia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Summary
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Dementia - Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update, provides an overview of the Dementia (Central Nervous System) pipeline landscape.
Dementia is the loss of mental functions such as thinking, memory, and reasoning that is severe enough to interfere with a person's daily functioning. Symptoms include memory loss, hallucinations, agitation, personality changes and difficulty with coordination and motor functions. Risk factors include age, smoking, obesity, high blood pressure, inflammation and cardiovascular diseases.
Report Highlights
Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Dementia - Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update, provides comprehensive information on the therapeutics under development for Dementia (Central Nervous System), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.
The Dementia (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Dementia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 1, 14, 43, 31, 2, 89, 58 and 3 respectively. Similarly, the Universities portfolio in Preclinical, Discovery and Unknown stages comprises 14, 5 and 1 molecules, respectively.
Dementia (Central Nervous System) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
Note:Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.
Scope
Summary
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Dementia - Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update, provides an overview of the Dementia (Central Nervous System) pipeline landscape.
Dementia is the loss of mental functions such as thinking, memory, and reasoning that is severe enough to interfere with a person's daily functioning. Symptoms include memory loss, hallucinations, agitation, personality changes and difficulty with coordination and motor functions. Risk factors include age, smoking, obesity, high blood pressure, inflammation and cardiovascular diseases.
Report Highlights
Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Dementia - Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update, provides comprehensive information on the therapeutics under development for Dementia (Central Nervous System), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.
The Dementia (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Dementia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 1, 14, 43, 31, 2, 89, 58 and 3 respectively. Similarly, the Universities portfolio in Preclinical, Discovery and Unknown stages comprises 14, 5 and 1 molecules, respectively.
Dementia (Central Nervous System) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
Note:Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.
Scope
- The pipeline guide provides a snapshot of the global therapeutic landscape of Dementia (Central Nervous System).
- The pipeline guide reviews pipeline therapeutics for Dementia (Central Nervous System) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Dementia (Central Nervous System) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Dementia (Central Nervous System) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Dementia (Central Nervous System)
- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Dementia (Central Nervous System).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Dementia (Central Nervous System) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
Companies Mentioned
Companies Mentioned
2N Pharma ApS
AbbVie Inc
Acadia Pharmaceuticals Inc
Actinogen Medical Ltd
AcuraStem Inc
Adamed Pharma SA
ADEL Inc
AFFiRiS AG
AgeneBio Inc
AIBIOS Co Ltd
Alector Inc
Alkermes Plc
AlphaCognition Inc
Alterity Therapeutics Ltd
Alzamend Neuro Inc
Amarantus Bioscience Holdings Inc
Anavex Life Sciences Corp
Anhorn Medicines Co Ltd
Annovis Bio Inc
Aphios Corp
Applied Genetic Technologies Corp
Aprinoia Therapeutics Inc
Aptinyx Inc
AriBio
Arkuda Therapeutics Inc
Arvinas Inc
Asahi Kasei Pharma Corp
Asceneuron SA
AskAt Inc
Astrogen Ltd
Athira Pharma Inc
AULBIO Co Ltd
Aurum Biosciences Ltd
Autifony Therapeutics Ltd
Avanir Pharmaceuticals Inc
AviadoBio Ltd
Avineuro Pharmaceuticals Inc
Avrion Therapeutics AG
Axon Neuroscience SE
Axsome Therapeutics Inc
Bioasis Technologies Inc
Biogen Inc
Biom Therapeutics LLC
Biorchestra Co Ltd
BioXcel Therapeutics Inc
CAMP4 Therapeutics Corp
Cellivery Therapeutics Inc
Cellular Biomedicine Group Ltd
Cennerv Pharma (S) Pte Ltd
Cerevel Therapeutics Holdings Inc
ChunLab Inc
Cogentis Therapeutics Inc
Cognition Therapeutics Inc
Cortice Biosciences Inc
Coya Therapeutics Inc
CSPC NBP Pharmaceutical Co Ltd
CuraSen Therapeutics Inc
Cyclerion Therapeutics Inc
Dadang & BIO Co Ltd
Daewoong Pharmaceutical Co Ltd
Denali Therapeutics Inc
DiaMedica Therapeutics Inc
Dongkook Pharmaceutical Co Ltd
Dr. August Wolff GmbH & Co KG Arzneimittel
Echo Pharmaceuticals BV
EIP Pharma LLC
Eisai Co Ltd
Eli Lilly and Co
ENCEFA
Ensol Biosciences Inc
Enterin Inc
EVER Neuro Pharma GmbH
Expansion Therapeutics Inc
Galimedix Therapeutics Ltd
Generian Pharmaceuticals Inc
Gismo Therapeutics Inc
GraySpace Therapeutics Inc
Guangzhou Magpie Pharmaceutical Co Ltd
HanAll Biopharma Co Ltd
Hemostemix Inc
Herophilus
HLB Pharmaceutical Co Ltd
Hyundai Pharma Co Ltd
IGC Pharma LLC
Immungenetics AG
ImStar Therapeutics Inc
Inhibikase Therapeutics Inc
Intra-Cellular Therapies Inc
IntraBio Ltd
Inventage Lab Inc
Ionis Pharmaceuticals Inc
IRLAB Therapeutics AB
Jazz Pharmaceuticals Plc
Johnson & Johnson
KeifeRx LLC
Kogenix Therapeutics Inc
Korea Pharma Co Ltd
Kuano Ltd
Kwang Dong Pharmaceutical Co Ltd
Lachesis Biosciences Ltd
Locanabio Inc
Luye Pharma Group Ltd
MediPost Co Ltd
Merck & Co Inc
Merz Pharma GmbH & Co KgaA
Metro International Biotech LLC
MGC Pharmaceuticals Ltd
MThera Pharma Co Ltd
MYND Life Sciences Inc
Neuramedy Co Ltd
Neurimmune Holding AG
Neurokine Therapeutics
NeuroScientific Biopharmaceuticals Ltd
NeuroTau Inc
Neuvivo Inc
NLS Pharmaceutics AG
Novartis AG
Novo Nordisk AS
Oligomerix inc
Orchard Therapeutics Plc
Oryzon Genomics SA
Otsuka Pharmaceutical Co Ltd
P2D Inc
Pacific Northwest Biotechnology LLC
Palisades Therapeutics
Park of Active Molecules
Passage Bio Inc
Plico Biotech Inc
Prediction BioSciences SAS
ProMIS Neurosciences Inc
Prothena Corp Plc
Psy Therapeutics Inc
PurMinds NeuroPharma Inc
QurAlis Corporation
Reata Pharmaceuticals Inc
Reborna Biosciences Inc
Resverlogix Corp
Reven Holdings Inc
Rubedo Life Sciences Inc
Sage Therapeutics Inc
Samus Therapeutics Inc
Shaperon Inc
Sinfonia Biotherapeutics Inc
Sio Gene Therapies Inc
SK Chemicals Co Ltd
SOLA Biosciences LLC
Stealth BioTherapeutics Corp
Stemedica Cell Technologies Inc
Sun Pharma Advanced Research Company Ltd
Suven Life Sciences Ltd
SyneuRx International Corp
T3D Therapeutics Inc
Targeted Pharmaceuticals LLC
TauRx Therapeutics Ltd
Teitur Trophics ApS
Theranexus SAS
Time Therapeutics Inc
Towa Pharmaceutical Co Ltd
Tranquis Therapeutics Inc
Transposon Therapeutics Inc
UCB SA
UniQure NV
Unity Biotechnology Inc
Vanqua Bio Inc
Vaxxinity Inc
Verge Genomics Inc
Voyager Therapeutics Inc
Wave Life Sciences Ltd
Whan In Pharm Co Ltd
Yumanity Therapeutics Inc
Companies Mentioned
2N Pharma ApS
AbbVie Inc
Acadia Pharmaceuticals Inc
Actinogen Medical Ltd
AcuraStem Inc
Adamed Pharma SA
ADEL Inc
AFFiRiS AG
AgeneBio Inc
AIBIOS Co Ltd
Alector Inc
Alkermes Plc
AlphaCognition Inc
Alterity Therapeutics Ltd
Alzamend Neuro Inc
Amarantus Bioscience Holdings Inc
Anavex Life Sciences Corp
Anhorn Medicines Co Ltd
Annovis Bio Inc
Aphios Corp
Applied Genetic Technologies Corp
Aprinoia Therapeutics Inc
Aptinyx Inc
AriBio
Arkuda Therapeutics Inc
Arvinas Inc
Asahi Kasei Pharma Corp
Asceneuron SA
AskAt Inc
Astrogen Ltd
Athira Pharma Inc
AULBIO Co Ltd
Aurum Biosciences Ltd
Autifony Therapeutics Ltd
Avanir Pharmaceuticals Inc
AviadoBio Ltd
Avineuro Pharmaceuticals Inc
Avrion Therapeutics AG
Axon Neuroscience SE
Axsome Therapeutics Inc
Bioasis Technologies Inc
Biogen Inc
Biom Therapeutics LLC
Biorchestra Co Ltd
BioXcel Therapeutics Inc
CAMP4 Therapeutics Corp
Cellivery Therapeutics Inc
Cellular Biomedicine Group Ltd
Cennerv Pharma (S) Pte Ltd
Cerevel Therapeutics Holdings Inc
ChunLab Inc
Cogentis Therapeutics Inc
Cognition Therapeutics Inc
Cortice Biosciences Inc
Coya Therapeutics Inc
CSPC NBP Pharmaceutical Co Ltd
CuraSen Therapeutics Inc
Cyclerion Therapeutics Inc
Dadang & BIO Co Ltd
Daewoong Pharmaceutical Co Ltd
Denali Therapeutics Inc
DiaMedica Therapeutics Inc
Dongkook Pharmaceutical Co Ltd
Dr. August Wolff GmbH & Co KG Arzneimittel
Echo Pharmaceuticals BV
EIP Pharma LLC
Eisai Co Ltd
Eli Lilly and Co
ENCEFA
Ensol Biosciences Inc
Enterin Inc
EVER Neuro Pharma GmbH
Expansion Therapeutics Inc
Galimedix Therapeutics Ltd
Generian Pharmaceuticals Inc
Gismo Therapeutics Inc
GraySpace Therapeutics Inc
Guangzhou Magpie Pharmaceutical Co Ltd
HanAll Biopharma Co Ltd
Hemostemix Inc
Herophilus
HLB Pharmaceutical Co Ltd
Hyundai Pharma Co Ltd
IGC Pharma LLC
Immungenetics AG
ImStar Therapeutics Inc
Inhibikase Therapeutics Inc
Intra-Cellular Therapies Inc
IntraBio Ltd
Inventage Lab Inc
Ionis Pharmaceuticals Inc
IRLAB Therapeutics AB
Jazz Pharmaceuticals Plc
Johnson & Johnson
KeifeRx LLC
Kogenix Therapeutics Inc
Korea Pharma Co Ltd
Kuano Ltd
Kwang Dong Pharmaceutical Co Ltd
Lachesis Biosciences Ltd
Locanabio Inc
Luye Pharma Group Ltd
MediPost Co Ltd
Merck & Co Inc
Merz Pharma GmbH & Co KgaA
Metro International Biotech LLC
MGC Pharmaceuticals Ltd
MThera Pharma Co Ltd
MYND Life Sciences Inc
Neuramedy Co Ltd
Neurimmune Holding AG
Neurokine Therapeutics
NeuroScientific Biopharmaceuticals Ltd
NeuroTau Inc
Neuvivo Inc
NLS Pharmaceutics AG
Novartis AG
Novo Nordisk AS
Oligomerix inc
Orchard Therapeutics Plc
Oryzon Genomics SA
Otsuka Pharmaceutical Co Ltd
P2D Inc
Pacific Northwest Biotechnology LLC
Palisades Therapeutics
Park of Active Molecules
Passage Bio Inc
Plico Biotech Inc
Prediction BioSciences SAS
ProMIS Neurosciences Inc
Prothena Corp Plc
Psy Therapeutics Inc
PurMinds NeuroPharma Inc
QurAlis Corporation
Reata Pharmaceuticals Inc
Reborna Biosciences Inc
Resverlogix Corp
Reven Holdings Inc
Rubedo Life Sciences Inc
Sage Therapeutics Inc
Samus Therapeutics Inc
Shaperon Inc
Sinfonia Biotherapeutics Inc
Sio Gene Therapies Inc
SK Chemicals Co Ltd
SOLA Biosciences LLC
Stealth BioTherapeutics Corp
Stemedica Cell Technologies Inc
Sun Pharma Advanced Research Company Ltd
Suven Life Sciences Ltd
SyneuRx International Corp
T3D Therapeutics Inc
Targeted Pharmaceuticals LLC
TauRx Therapeutics Ltd
Teitur Trophics ApS
Theranexus SAS
Time Therapeutics Inc
Towa Pharmaceutical Co Ltd
Tranquis Therapeutics Inc
Transposon Therapeutics Inc
UCB SA
UniQure NV
Unity Biotechnology Inc
Vanqua Bio Inc
Vaxxinity Inc
Verge Genomics Inc
Voyager Therapeutics Inc
Wave Life Sciences Ltd
Whan In Pharm Co Ltd
Yumanity Therapeutics Inc
Table of Contents
476 Pages
- Introduction
- Global Markets Direct Report Coverage
- Dementia - Overview
- Dementia - Therapeutics Development
- Pipeline Overview
- Pipeline by Companies
- Pipeline by Universities/Institutes
- Products under Development by Companies
- Products under Development by Universities/Institutes
- Dementia - Therapeutics Assessment
- Assessment by Target
- Assessment by Mechanism of Action
- Assessment by Route of Administration
- Assessment by Molecule Type
- Dementia - Companies Involved in Therapeutics Development
- Dementia - Drug Profiles
- Dementia - Dormant Projects
- Dementia - Discontinued Products
- Dementia - Product Development Milestones
- Featured News & Press Releases
- Appendix
- Methodology
- Coverage
- Secondary Research
- Primary Research
- Expert Panel Validation
- Contact Us
- Disclaimer
- List of Tables
- Number of Products under Development for Dementia, 2022
- Number of Products under Development by Companies, 2022
- Number of Products under Development by Universities/Institutes, 2022
- Products under Development by Companies, 2022
- Products under Development by Universities/Institutes, 2022
- Number of Products by Stage and Target, 2022
- Number of Products by Stage and Target, 2022 (Contd..1)
- Number of Products by Stage and Target, 2022 (Contd..2)
- Number of Products by Stage and Target, 2022 (Contd..3)
- Number of Products by Stage and Mechanism of Action, 2022
- Number of Products by Stage and Mechanism of Action, 2022 (Contd..1)
- Number of Products by Stage and Mechanism of Action, 2022 (Contd..2)
- Number of Products by Stage and Mechanism of Action, 2022 (Contd..3)
- Number of Products by Stage and Route of Administration, 2022
- Number of Products by Stage and Molecule Type, 2022
- Dementia - Pipeline by 2N Pharma ApS, 2022
- Dementia - Pipeline by AbbVie Inc, 2022
- Dementia - Pipeline by Acadia Pharmaceuticals Inc, 2022
- Dementia - Pipeline by Actinogen Medical Ltd, 2022
- Dementia - Pipeline by AcuraStem Inc, 2022
- Dementia - Pipeline by Adamed Pharma SA, 2022
- Dementia - Pipeline by ADEL Inc, 2022
- Dementia - Pipeline by AFFiRiS AG, 2022
- Dementia - Pipeline by AgeneBio Inc, 2022
- Dementia - Pipeline by AIBIOS Co Ltd, 2022
- Dementia - Pipeline by Alector Inc, 2022
- Dementia - Pipeline by Alkermes Plc, 2022
- Dementia - Pipeline by AlphaCognition Inc, 2022
- Dementia - Pipeline by Alterity Therapeutics Ltd, 2022
- Dementia - Pipeline by Alzamend Neuro Inc, 2022
- Dementia - Pipeline by Amarantus Bioscience Holdings Inc, 2022
- Dementia - Pipeline by Anavex Life Sciences Corp, 2022
- Dementia - Pipeline by Anhorn Medicines Co Ltd, 2022
- Dementia - Pipeline by Annovis Bio Inc, 2022
- Dementia - Pipeline by Aphios Corp, 2022
- Dementia - Pipeline by Applied Genetic Technologies Corp, 2022
- Dementia - Pipeline by Aprinoia Therapeutics Inc, 2022
- Dementia - Pipeline by Aptinyx Inc, 2022
- Dementia - Pipeline by AriBio, 2022
- Dementia - Pipeline by Arkuda Therapeutics Inc, 2022
- Dementia - Pipeline by Arvinas Inc, 2022
- Dementia - Pipeline by Asahi Kasei Pharma Corp, 2022
- Dementia - Pipeline by Asceneuron SA, 2022
- Dementia - Pipeline by AskAt Inc, 2022
- Dementia - Pipeline by Astrogen Ltd, 2022
- Dementia - Pipeline by Athira Pharma Inc, 2022
- Dementia - Pipeline by AULBIO Co Ltd, 2022
- Dementia - Pipeline by Aurum Biosciences Ltd, 2022
- Dementia - Pipeline by Autifony Therapeutics Ltd, 2022
- Dementia - Pipeline by Avanir Pharmaceuticals Inc, 2022
- Dementia - Pipeline by AviadoBio Ltd, 2022
- Dementia - Pipeline by Avineuro Pharmaceuticals Inc, 2022
- Dementia - Pipeline by Avrion Therapeutics AG, 2022
- Dementia - Pipeline by Axon Neuroscience SE, 2022
- Dementia - Pipeline by Axsome Therapeutics Inc, 2022
- Dementia - Pipeline by Bioasis Technologies Inc, 2022
- Dementia - Pipeline by Biogen Inc, 2022
- Dementia - Pipeline by Biom Therapeutics LLC, 2022
- Dementia - Pipeline by Biorchestra Co Ltd, 2022
- Dementia - Pipeline by BioXcel Therapeutics Inc, 2022
- Dementia - Pipeline by CAMP4 Therapeutics Corp, 2022
- Dementia - Pipeline by Cellivery Therapeutics Inc, 2022
- Dementia - Pipeline by Cellular Biomedicine Group Ltd, 2022
- Dementia - Pipeline by Cennerv Pharma (S) Pte Ltd, 2022
- Dementia - Pipeline by Cerevel Therapeutics Holdings Inc, 2022
- Dementia - Pipeline by ChunLab Inc, 2022
- Dementia - Pipeline by Cogentis Therapeutics Inc, 2022
- Dementia - Pipeline by Cognition Therapeutics Inc, 2022
- Dementia - Pipeline by Cortice Biosciences Inc, 2022
- Dementia - Pipeline by Coya Therapeutics Inc, 2022
- Dementia - Pipeline by CSPC NBP Pharmaceutical Co Ltd, 2022
- Dementia - Pipeline by CuraSen Therapeutics Inc, 2022
- Dementia - Pipeline by Cyclerion Therapeutics Inc, 2022
- Dementia - Pipeline by Dadang & BIO Co Ltd, 2022
- Dementia - Pipeline by Daewoong Pharmaceutical Co Ltd, 2022
- Dementia - Pipeline by Denali Therapeutics Inc, 2022
- Dementia - Pipeline by DiaMedica Therapeutics Inc, 2022
- Dementia - Pipeline by Dongkook Pharmaceutical Co Ltd, 2022
- Dementia - Pipeline by Dr. August Wolff GmbH & Co KG Arzneimittel, 2022
- Dementia - Pipeline by Echo Pharmaceuticals BV, 2022
- Dementia - Pipeline by EIP Pharma LLC, 2022
- Dementia - Pipeline by Eisai Co Ltd, 2022
- Dementia - Pipeline by Eli Lilly and Co, 2022
- Dementia - Pipeline by ENCEFA, 2022
- Dementia - Pipeline by Ensol Biosciences Inc, 2022
- Dementia - Pipeline by Enterin Inc, 2022
- Dementia - Pipeline by EVER Neuro Pharma GmbH, 2022
- Dementia - Pipeline by Expansion Therapeutics Inc, 2022
- Dementia - Pipeline by Galimedix Therapeutics Ltd, 2022
- Dementia - Pipeline by Generian Pharmaceuticals Inc, 2022
- Dementia - Pipeline by Gismo Therapeutics Inc, 2022
- Dementia - Pipeline by GraySpace Therapeutics Inc, 2022
- Dementia - Pipeline by Guangzhou Magpie Pharmaceutical Co Ltd, 2022
- Dementia - Pipeline by HanAll Biopharma Co Ltd, 2022
- Dementia - Pipeline by Hemostemix Inc, 2022
- Dementia - Pipeline by Herophilus, 2022
- Dementia - Pipeline by HLB Pharmaceutical Co Ltd, 2022
- Dementia - Pipeline by Hyundai Pharma Co Ltd, 2022
- Dementia - Pipeline by IGC Pharma LLC, 2022
- Dementia - Pipeline by Immungenetics AG, 2022
- Dementia - Pipeline by ImStar Therapeutics Inc, 2022
- Dementia - Pipeline by Inhibikase Therapeutics Inc, 2022
- Dementia - Pipeline by Intra-Cellular Therapies Inc, 2022
- Dementia - Pipeline by IntraBio Ltd, 2022
- Dementia - Pipeline by Inventage Lab Inc, 2022
- Dementia - Pipeline by Ionis Pharmaceuticals Inc, 2022
- Dementia - Pipeline by IRLAB Therapeutics AB, 2022
- Dementia - Pipeline by Jazz Pharmaceuticals Plc, 2022
- Dementia - Pipeline by Johnson & Johnson, 2022
- Dementia - Pipeline by KeifeRx LLC, 2022
- Dementia - Pipeline by Kogenix Therapeutics Inc, 2022
- Dementia - Pipeline by Korea Pharma Co Ltd, 2022
- Dementia - Pipeline by Kuano Ltd, 2022
- Dementia - Pipeline by Kwang Dong Pharmaceutical Co Ltd, 2022
- Dementia - Pipeline by Lachesis Biosciences Ltd, 2022
- Dementia - Pipeline by Locanabio Inc, 2022
- Dementia - Pipeline by Luye Pharma Group Ltd, 2022
- Dementia - Pipeline by MediPost Co Ltd, 2022
- Dementia - Pipeline by Merck & Co Inc, 2022
- Dementia - Pipeline by Merz Pharma GmbH & Co KgaA, 2022
- Dementia - Pipeline by Metro International Biotech LLC, 2022
- Dementia - Pipeline by MGC Pharmaceuticals Ltd, 2022
- Dementia - Pipeline by MThera Pharma Co Ltd, 2022
- Dementia - Pipeline by MYND Life Sciences Inc, 2022
- Dementia - Pipeline by Neuramedy Co Ltd, 2022
- Dementia - Pipeline by Neurimmune Holding AG, 2022
- Dementia - Pipeline by Neurokine Therapeutics, 2022
- Dementia - Pipeline by NeuroScientific Biopharmaceuticals Ltd, 2022
- Dementia - Pipeline by NeuroTau Inc, 2022
- Dementia - Pipeline by Neuvivo Inc, 2022
- Dementia - Pipeline by NLS Pharmaceutics AG, 2022
- Dementia - Pipeline by Novartis AG, 2022
- Dementia - Pipeline by Novo Nordisk AS, 2022
- Dementia - Pipeline by Oligomerix inc, 2022
- Dementia - Pipeline by Orchard Therapeutics Plc, 2022
- Dementia - Pipeline by Oryzon Genomics SA, 2022
- Dementia - Pipeline by Otsuka Pharmaceutical Co Ltd, 2022
- Dementia - Pipeline by P2D Inc, 2022
- Dementia - Pipeline by Pacific Northwest Biotechnology LLC, 2022
- Dementia - Pipeline by Palisades Therapeutics, 2022
- Dementia - Pipeline by Park of Active Molecules, 2022
- Dementia - Pipeline by Passage Bio Inc, 2022
- Dementia - Pipeline by Plico Biotech Inc, 2022
- Dementia - Pipeline by Prediction BioSciences SAS, 2022
- Dementia - Pipeline by ProMIS Neurosciences Inc, 2022
- Dementia - Pipeline by Prothena Corp Plc, 2022
- Dementia - Pipeline by Psy Therapeutics Inc, 2022
- Dementia - Pipeline by PurMinds NeuroPharma Inc, 2022
- Dementia - Pipeline by QurAlis Corporation, 2022
- Dementia - Pipeline by Reata Pharmaceuticals Inc, 2022
- Dementia - Pipeline by Reborna Biosciences Inc, 2022
- Dementia - Pipeline by Resverlogix Corp, 2022
- Dementia - Pipeline by Reven Holdings Inc, 2022
- Dementia - Pipeline by Rubedo Life Sciences Inc, 2022
- Dementia - Pipeline by Sage Therapeutics Inc, 2022
- Dementia - Pipeline by Samus Therapeutics Inc, 2022
- Dementia - Pipeline by Shaperon Inc, 2022
- Dementia - Pipeline by Sinfonia Biotherapeutics Inc, 2022
- Dementia - Pipeline by Sio Gene Therapies Inc, 2022
- Dementia - Pipeline by SK Chemicals Co Ltd, 2022
- Dementia - Pipeline by SOLA Biosciences LLC, 2022
- Dementia - Pipeline by Stealth BioTherapeutics Corp, 2022
- Dementia - Pipeline by Stemedica Cell Technologies Inc, 2022
- Dementia - Pipeline by Sun Pharma Advanced Research Company Ltd, 2022
- Dementia - Pipeline by Suven Life Sciences Ltd, 2022
- Dementia - Pipeline by SyneuRx International Corp, 2022
- Dementia - Pipeline by T3D Therapeutics Inc, 2022
- Dementia - Pipeline by Targeted Pharmaceuticals LLC, 2022
- Dementia - Pipeline by TauRx Therapeutics Ltd, 2022
- Dementia - Pipeline by Teitur Trophics ApS, 2022
- Dementia - Pipeline by Theranexus SAS, 2022
- Dementia - Pipeline by Time Therapeutics Inc, 2022
- Dementia - Pipeline by Towa Pharmaceutical Co Ltd, 2022
- Dementia - Pipeline by Tranquis Therapeutics Inc, 2022
- Dementia - Pipeline by Transposon Therapeutics Inc, 2022
- Dementia - Pipeline by UCB SA, 2022
- Dementia - Pipeline by UniQure NV, 2022
- Dementia - Pipeline by Unity Biotechnology Inc, 2022
- Dementia - Pipeline by Vanqua Bio Inc, 2022
- Dementia - Pipeline by Vaxxinity Inc, 2022
- Dementia - Pipeline by Verge Genomics Inc, 2022
- Dementia - Pipeline by Voyager Therapeutics Inc, 2022
- Dementia - Pipeline by Wave Life Sciences Ltd, 2022
- Dementia - Pipeline by Whan In Pharm Co Ltd, 2022
- Dementia - Pipeline by Yumanity Therapeutics Inc, 2022
- Dementia - Dormant Projects, 2022
- Dementia - Discontinued Products, 2022
- List of Figures
- Number of Products under Development for Dementia, 2022
- Number of Products under Development by Companies, 2022
- Number of Products under Development by Universities/Institutes, 2022
- Number of Products by Targets, 2022
- Number of Products by Stage and Top 10 Targets, 2022
- Number of Products by Top 10 Mechanism of Actions, 2022
- Number of Products by Stage and Top 10 Mechanism of Actions, 2022
- Number of Products by Top 10 Routes of Administration, 2022
- Number of Products by Stage and Top 10 Routes of Administration, 2022
- Number of Products by Top 10 Molecule Types, 2022
- Number of Products by Stage and Top 10 Molecule Types, 2022
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
